Journey Medical (DERM) Times Interest Earned (2020 - 2026)
Journey Medical (DERM) posted Times Interest Earned of -$0.47 for Q1 2026, down 37.85% on a QoQ basis from -$0.34 in Q4 2025, and up 63.13% year-over-year from -$0.29 in Q1 2025.
Journey Medical (DERM) Times Interest Earned (2020 - 2026) Analysis & Trends
Journey Medical's Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.47 for Q1 2026.
- Quarterly Times Interest Earned rose 63.13% year-over-year to -$0.47 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.01 (up 24.64% YoY) and the FY2025 annual result came in at -$0.31, down 14129.67% from the prior year.
- Times Interest Earned was -$0.47 for Q1 2026 at Journey Medical, down from -$0.34 in the prior quarter.
- Across five years, Times Interest Earned topped out at $4.26 in Q4 2024 and bottomed at -$14.71 in Q1 2023.
- A 5-year average of -$1.78 and a median of -$0.47 in 2026 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 244.74% in 2023, while the deepest fall reached 544.36% in 2023.
- Journey Medical's Times Interest Earned stood at -$7.64 in 2022, then jumped by 150.38% to $3.85 in 2023, then climbed by 10.84% to $4.26 in 2024, then slumped by 108.04% to -$0.34 in 2025, then sank by 37.85% to -$0.47 in 2026.
- Business Quant data shows DERM's Times Interest Earned at -$0.47 in Q1 2026, -$0.34 in Q4 2025, and -$0.28 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | -0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.47 |
| Dec 31, 2025 | -0.34 |
| Sep 30, 2025 | -0.28 |
| Jun 30, 2025 | -0.20 |
| Mar 31, 2025 | -1.28 |
| Dec 31, 2024 | 4.26 |
| Sep 30, 2024 | -0.27 |
| Jun 30, 2024 | -0.27 |
| Mar 31, 2024 | -6.33 |
| Dec 31, 2023 | 3.85 |
| Sep 30, 2023 | 4.20 |
| Jun 30, 2023 | -4.31 |
| Mar 31, 2023 | -14.71 |
| Dec 31, 2022 | -7.64 |
| Sep 30, 2022 | -2.90 |
| Jun 30, 2022 | -1.22 |
| Mar 31, 2022 | -2.28 |
| Dec 31, 2021 | -2.21 |
| Sep 30, 2021 | -1.62 |
| Jun 30, 2021 | -10.26 |